General
Medical Cannabis Program - Program Update 03/22/2022
All 2021 HAN Alerts ( Except December)
Wound Botulizm - 01-12-2021, COVID-19 Non-Hospital Therapeutics Admin Application - 01-21-2021, Wound Botulism - 01-21-2021, COVID-19 Pediatric Covid Testing - 02-01-2021, Advisory Requirements For TB Testing Of HCW Resumes - 04-01-2021, COVID-19 Vaccine Eligibility - 06-04-2021, COVID-19 Pause in J&J Distribution - 04-13-2021, COVID-19 Third Dose FOr Immunocompromised - 04-16-2021, NMMAT Pfizer Vaccine Recommendation 12 Years and Older - 05-13-2021, COVID-19 VaST Technical Report - 06-24-2021, Sodium Citate Lab Tube Shortage - 06-06-2021, COVID-19 Vaccine Data Improvement - 06-13-2021, COVID-19 Clinical Guidance Myocarditis Following mRNA Vaccination - 06-25-2021, RSV Surveillance - 07-22-2021, COVID-19 No Boosters Yet - 08-03-2021, COVID-19 Invermectin Toxicity - 09-10-2021.December 2022 HAN Alerts
CDC 00438 - 12-17-2021, Shigella In Metro Homeless - 12-16-2021, COVID-19 Boosters for 16-17 - 12-09-2021, COVID-19 Evusheld - mAb - 12-08-2021, COVID-19 CDC 459 Varient Of Concern Identified - Omicron - 12-01-2021.MCAB Meeting Notice 03-22-2022
January 2022 HAN Alerts
Updated Guidance on Managing Healthcare Personnel with Infection or Exposure - 01-05-2022, CDC and FDA Update Indications for Pfizer-BioNTech COVID-19 Vaccine - 01-06-2022, Update on Omicron and COVID-19 Therapeutics - 01-07-2022, CDC and FDA Shorten Booster Interval for Moderna COVID-19 Vaccine - 01-10-2022, Public Health Order Enforcement to start 2/4/2022 of Up To Date Vaccination of Status - 01-14-2022, Therapeutics Update:Eligibility Criteria & Oral Antiviral & Monoclonal Antibody - 01-25-2022, Requirements on Electronic Death Certifications - 01-24-2022.February 2022 HAN Alerts
Guidance for immunocompromised - 02-15-2022 , COVID Therapeutics - Quick Reference for Prescribers - 02-16-2022, COVID-19 Therapeutics Update: Patient Eligibility Criteria & New COVID-19 Therapeutic - 02-16-2022, COVID -19 Dealth Risk Increases as the Number of Comorbid Conditions Increases - 02-16-2022, COVID -19 Dealth Risk for Select Age Groups and Comorbid Conditions - 02-16-2022, Update for Providers regarding COVID-19 & Immunocompromised Patients - 02-22-2022, COVID-19 Therapeutics Update: Evusheld - 02-28-2022.This is a list of provider names.
Current Advisory Council Members List
Naloxone Standing Order for Opioid Treatment Centers/Programs
Notice of Minor, Nonsubstantive Correction 7.1.32
This memo was released by the emergency medical services commission to address licensed emergency medical services personnel who have been convicted of driving under the influence and sentenced to having an ignition interlock device installed on their personal vehicles as part of their rehabilitation.
Naloxone (or other opioid antagonist) Statewide Standing Order for Registered Pharmacists
Naloxone (or other opioid antagonist) Standing Order Prescription Hardcopy
OMI Reportable Deaths on Death Certificates
Family Planning Program (FPP)2021 Title X Regulation and Protocol Update
Background Check Supplement
Medical Cannabis Program - Program Update 12/10/2021